Mobile Health Intervention to Increase Activity in Heart Failure Study
MOVIN-HF
MObile Health Intervention to INcrease Activity in Heart Failure Study: A Micro-Randomized Trial
2 other identifiers
interventional
50
1 country
1
Brief Summary
Physical activity is known to help patients with heart failure feel better and live longer though few patients with heart failure are sufficiently active. This study is evaluating whether a mobile health intervention can help patients with heart failure increase physical activity levels and remain active over time. The mobile health intervention consists of three parts: Notifications encouraging physical activity, a digital health coach trained in motivational interviewing, and a mobile application which encourages goal setting and activity monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Aug 2026
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedFirst Posted
Study publicly available on registry
August 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
August 6, 2026
August 1, 2026
1.3 years
July 25, 2026
August 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Step count 4 hours after a decision point for micro-randomized messages
4 hours after a decision point
Secondary Outcomes (5)
Change in mean daily step count from baseline to 3 months
Baseline, 3 months
Percentage of transcripts with a recommendation that is deemed unsafe by the study team
3-month intervention
Changes in autonomous motivation from baseline to 3 months on the Behavioral Regulation in Exercise Questionnaire version 3 (BREQ-3)
Baseline, 3 months
Change in controlled motivation from baseline to 3 months on the Behavioral Regulation in Exercise Questionnaire version 3 (BREQ-3).
Baseline, 3 months
Change in mean daily step count by week over the study duration
Weekly up to 3 months (intervention period)
Study Arms (1)
Mobile application intervention
EXPERIMENTALAll participants will have a 1-week baseline period to establish participants pre-intervention step counts.
Interventions
Following a baseline period, participants will receive a 12 week mobile health intervention consisting of 3 main components: (1) a mobile application which supports goal-setting and self-monitoring; (2) an artificial intelligence (AI)-based health coach within the mobile application trained in principles of motivational interviewing and tailored to the needs of patients with heart failure (3) micro-randomized messages designed to enhance perceived competence around physical activity and promoting low level physical activity.
Eligibility Criteria
You may qualify if:
- Michigan Medicine patient with a diagnosis of heart failure (HF)
- Age 18 years and older at screening and able to provide consent
- New York Heart Association class 2 or 3 HF symptoms
- Safe for home physical activity as determined by treating clinician
- Own a smartphone with a compatible Apple or Android operating system
- Fluent in spoken and written English
You may not qualify if:
- Hospitalized for HF within the prior 6 weeks
- Orthopedic or neurological condition significantly limiting physical activity
- Greater than mild cognitive impairment
- Enrolled in hospice care
- Severe valvular stenosis
- Exercise-induced ventricular tachycardia
- Obstructive left main or proximal left anterior descending coronary artery disease
- Pulmonary hypertension treated with inhaled or intravenous therapy
- Currently pregnant or planning to become pregnant
- Determined to be unsafe for participation as assessed by the investigative team.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Golbus, MD, MS
University of Michigan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Cardiology
Study Record Dates
First Submitted
July 25, 2026
First Posted
August 6, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
August 6, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After study completion.
- Access Criteria
- De-identified dataset that will be published online and which will be shared with other researchers upon request.
After study completion, the investigators will generate a de-identified dataset that will be published online and which will be shared with other researchers upon request.